Abstract
The results of short term (8-day) and longer term (28-day) pharmacokinetic studies in healthy male volunteers (n = 27) indicate that steady-state plasma bunazosin concentrations are achieved within 8 to 14 days on initiating multiple oral dose administration of a sustained-release formulation of bunazosin (Bunazosin Retard®) 6mg once daily. There is no evidence of bunazosin accumulation with multiple oral dose administration.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
